Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Alcon

Status and phase: Completed; Phase 2

Conditions: Open-Angle Glaucoma; Ocular Hypertension

Treatments: Drug: Glaucoma therapy

Study type: Interventional

Funder types: Industry

Identifiers

NCT00069719

C-02-33

Details and patient eligibility

About

To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension;
• logMAR visual acuity not worse than 0.6.

Exclusion criteria

• Clinically relevant ophthalmic or systemic conditions may be excluded.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind